Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ.
Libertinova J, Meluzinova E, Tomek A, Horakova D, Kovarova I, Matoska V, Kumstyrova S, Zajac M, Hyncicova E, Liskova P, Houzvickova E, Martinkovic L, Bojar M, Havrdova E, Marusic P. Libertinova J, et al. Among authors: meluzinova e. PLoS One. 2017 Jan 12;12(1):e0169957. doi: 10.1371/journal.pone.0169957. eCollection 2017. PLoS One. 2017. PMID: 28081207 Free PMC article. Clinical Trial.
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.
Bojar M, Zajac M, Meluzínová E, Houžvičková E, Libertinová J, Lišková P, Mat'oška V, Nyč O, Mináriková M. Bojar M, et al. Among authors: meluzinova e. Mult Scler. 2010 Dec;16(12):1529-30; author reply 1531-2. doi: 10.1177/1352458510382248. Epub 2010 Sep 9. Mult Scler. 2010. PMID: 20829243 No abstract available.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Kappos L, Gold R, Miller DH, MacManus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Eraksoy M, Meluzinova E, Dufek M, Yang M, Dawson K, O'Neill GN. Kappos L, et al. Among authors: meluzinova e. Mult Scler. 2012 Mar;18(3):314-21. doi: 10.1177/1352458511421054. Epub 2011 Aug 30. Mult Scler. 2012. PMID: 21878455 Clinical Trial.
Management of psoriasis vulgaris and multiple sclerosis with fumaric acid.
Gkalpakiotis S, Arenberger P, Gkalpakioti P, Meluzinova E, Chandran D, Arenbergerova M. Gkalpakiotis S, et al. Among authors: meluzinova e. J Am Acad Dermatol. 2014 Mar;70(3):e60-1. doi: 10.1016/j.jaad.2013.10.031. J Am Acad Dermatol. 2014. PMID: 24528918 Free article. Review. No abstract available.
MxA mRNA decrease preceding NAb detection in IFNβ-treated MS patients.
Libertinova J, Meluzinova E, Matoska V, Zajac M, Kovarova I, Havrdova E, Horakova D, Tomek A, Marusic P, Bojar M. Libertinova J, et al. Among authors: meluzinova e. Brain Behav. 2017 Feb 9;7(3):e00644. doi: 10.1002/brb3.644. eCollection 2017 Mar. Brain Behav. 2017. PMID: 28293479 Free PMC article.
Elevated D-dimer as an immediate response to alemtuzumab treatment.
Libertinova J, Meluzinova E, Nema E, Rockova P, Elisak M, Petrzalka M, Mojzisova H, Hammer J, Tomek A, Marusic P. Libertinova J, et al. Among authors: meluzinova e. Mult Scler. 2021 Jan;27(1):151-154. doi: 10.1177/1352458520904277. Epub 2020 Feb 20. Mult Scler. 2021. PMID: 32077356
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic.
Hradilek P, Meluzinova E, Zapletalova O, Hanulikova P, Horakova D, Woznicova I, Pavliska L, Stetkarova I, Valis M, Stourac P, Adamkova J, Ampapa R, Vachova M, Mares J. Hradilek P, et al. Among authors: meluzinova e. Mult Scler Relat Disord. 2022 Mar;59:103391. doi: 10.1016/j.msard.2021.103391. Epub 2021 Nov 28. Mult Scler Relat Disord. 2022. PMID: 35240415
35 results